Search alternatives:
marked decrease » marked increase (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
19 n » 19 _ (Expand Search), 19 p (Expand Search), 1 n (Expand Search)
Showing 1 - 20 results of 1,125 for search '(( ct ((((largest decrease) OR (marked decrease))) OR (larger decrease)) ) OR ( 19 n decrease ))', query time: 0.66s Refine Results
  1. 1
    Trust levels before and after the COVID-19 pandemic (n = 10,000).

    Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Average change in trust in science by country (n = 10,000).

    Average change in trust in science by country (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Studies measuring patient-level impact (N = 6, 19% of included studies).

    Studies measuring patient-level impact (N = 6, 19% of included studies). by Emily M. Jones (21989800)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Subject characteristics (n = 45).

    Subject characteristics (n = 45). by Min Wang (21070)

    Published 2024
    Save to List
    Saved in:
  6. 6
    Further characterization of N19 and calcium dependence.

    Further characterization of N19 and calcium dependence. by Elham Karamooz (2584474)

    Published 2025
    “…<p>(<b>A</b>) N19 decreases MR1 presentation of Mtb when added at the same time as infection. 25µM N19 was added to BEAS-2Bs the same time as Mtb (MOI 8). …”
    Save to List
    Saved in:
  7. 7
    Distribution of individual change in trust in science before and after the pandemic (n = 10,000).

    Distribution of individual change in trust in science before and after the pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Cancer virtual patients with decreased initial neutrophil concentrations have higher viral load peaks.

    Cancer virtual patients with decreased initial neutrophil concentrations have higher viral load peaks. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Descriptives of the study sample, N = 451.

    Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Demographics, anthropometrics, and biochemical parameters between pre- and post-bariatric surgery (n = 19).

    Demographics, anthropometrics, and biochemical parameters between pre- and post-bariatric surgery (n = 19). by Manal Ali Ahmad (16868808)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Boxplot comparing Ct values for HD in flies and clothes.

    Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein.

    Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Demographic information of respondents (N = 1,143).

    Demographic information of respondents (N = 1,143). by Adaobi Uchenna Mosanya (20384248)

    Published 2024
    Save to List
    Saved in:
  18. 18
    Neutralization fingerprinting of nAbs on a neutralization sensitive Env mutant panel (SENSE-19).

    Neutralization fingerprinting of nAbs on a neutralization sensitive Env mutant panel (SENSE-19). by Caio Foulkes (20592250)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Demographic summary of interview participants (n = 15).

    Demographic summary of interview participants (n = 15). by Yan Li (23143)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Correlation between HRV and cognitive performance variables (n = 45).

    Correlation between HRV and cognitive performance variables (n = 45). by Min Wang (21070)

    Published 2024
    Save to List
    Saved in:

Search Tools: